Aminophylline is indicated for:
Population group: both men and women, only children (1 year - 12 years old) , adolescents (12 years - 18 years old) , adults (18 years old or older)
Aminophylline is indicated for diseases of the cardiovascular system (e.g. an adjunct in the treatment of pulmonary oedema or paroxysmal nocturnal dyspnoea caused by left ventricular heart failure), reversible airways obstruction including status asthmaticus and acute bronchospasm.
For this indication, competent medicine agencies globally authorize below treatments (click for details):
Aminophylline is contraindicated in the following cases: